---
figid: PMC7217787__gr1_lrg
figtitle: Rapamycin use in COVID-19
organisms:
- Severe acute respiratory syndrome coronavirus 2
- unidentified influenza virus
- H1N1 subtype
- Betacoronavirus
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7217787
filename: gr1_lrg.jpg
figlink: pmc/articles/PMC7217787/figure/f0005/
number: F1
caption: 'Rapamycin use in COVID-19. ①SARS-CoV-2 entry into lungs through respiratory
  droplets ②Alveolar (Type II) Epithelial cell zoomSARS-CoV-2 bindingACE2 and entry
  into Alveolar (Type II) Epithelial cell SARS-CoV-2 replication into Alveolar (Type
  II) Epithelial cell Cell apoptosis releasing DAMPs Innate immune cells recruitment
  ROS releasing Innate immune response with chemokines and cytokines release ③ DC
  Zoom Binding SARS-CoV-2 to TLR Activation of NFkB signaling pathway Activation of
  PI3K/AKT/mTOR signaling pathway Activation NLRP3 inflammasome pathway by the ROS
  as result of SARS-CoV-2 binding ACE2 Production of IL-1β by Caspase-1 from pro-
  IL-1β Caspase-1 mediate cell pyroptosis Rapamycin blocks mTOR and finally limits
  IL-1β and IL-6 production as well as pyroptosis ④ Preferential differentiation of
  ETC, TH1 and TH17 by activation of mTORC1 pathway by ROS ⑤ ROS, Pyroptosis, extensive
  and prolonged cytokines release lead to immunosenescence Expression of senescent
  markers such as PD-1 Senescent Associated Secretory Phenotype (SASP) with IL-1,
  IL-6, IL-8, TNFα, Chemokines, MMPs, and Growth Factors ⑥ Critical phase of SARS-CoV-2
  infection with Cytokine Storm and immunoscenescence SASP and Pyroptosis lead to
  Macrophages, Monocytes, PMNs recruitment and cytokines release. SASP, Pyroptosis,
  and cytokines released by Macrophages, Monocytes, and PMNs are the main components
  of CYTOKINE STORM CD8+ T lymphocytes senescence under cytokine storm and extensive
  SARS-CoV-2 replication : Cytokine storm increases the numbers of STC expressing
  the senescent marker PD-1 PD-1+ STC become unable to secrete IFN-γ, Perforin, and
  Granzyme, and eventually kill the infected cell ⑦ Kinetics of SARS-CoV-2 infection
  and window of opportunity for rapamycin treatment Abbreviations: DAMPs: Damage Associated
  Molecular Paterns; PMNs : Polymorphonuclear Leukocytes ; ROS: Reactive Oxygen Species;
  DC : Dendritic Cell ; TLR : Toll Like Receptor ; ACE2 : Angiotensin Converting Enzyme
  2; MAVS : Mitochondrial Anti-Viral Signaling; STC : Senescent T Cell; ETC: Effector
  T Cell; MTC: Memory T Cell; ARDS : acute respiratory distress syndrome.'
papertitle: Targeting T-cell senescence and cytokine storm with rapamycin to prevent
  severe progression in COVID-19.
reftext: Loukman Omarjee, et al. Clin Immunol. 2020 Jul;216:108464-108464.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9202594
figid_alias: PMC7217787__F1
figtype: Figure
redirect_from: /figures/PMC7217787__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7217787__gr1_lrg.html
  '@type': Dataset
  description: 'Rapamycin use in COVID-19. ①SARS-CoV-2 entry into lungs through respiratory
    droplets ②Alveolar (Type II) Epithelial cell zoomSARS-CoV-2 bindingACE2 and entry
    into Alveolar (Type II) Epithelial cell SARS-CoV-2 replication into Alveolar (Type
    II) Epithelial cell Cell apoptosis releasing DAMPs Innate immune cells recruitment
    ROS releasing Innate immune response with chemokines and cytokines release ③ DC
    Zoom Binding SARS-CoV-2 to TLR Activation of NFkB signaling pathway Activation
    of PI3K/AKT/mTOR signaling pathway Activation NLRP3 inflammasome pathway by the
    ROS as result of SARS-CoV-2 binding ACE2 Production of IL-1β by Caspase-1 from
    pro- IL-1β Caspase-1 mediate cell pyroptosis Rapamycin blocks mTOR and finally
    limits IL-1β and IL-6 production as well as pyroptosis ④ Preferential differentiation
    of ETC, TH1 and TH17 by activation of mTORC1 pathway by ROS ⑤ ROS, Pyroptosis,
    extensive and prolonged cytokines release lead to immunosenescence Expression
    of senescent markers such as PD-1 Senescent Associated Secretory Phenotype (SASP)
    with IL-1, IL-6, IL-8, TNFα, Chemokines, MMPs, and Growth Factors ⑥ Critical phase
    of SARS-CoV-2 infection with Cytokine Storm and immunoscenescence SASP and Pyroptosis
    lead to Macrophages, Monocytes, PMNs recruitment and cytokines release. SASP,
    Pyroptosis, and cytokines released by Macrophages, Monocytes, and PMNs are the
    main components of CYTOKINE STORM CD8+ T lymphocytes senescence under cytokine
    storm and extensive SARS-CoV-2 replication : Cytokine storm increases the numbers
    of STC expressing the senescent marker PD-1 PD-1+ STC become unable to secrete
    IFN-γ, Perforin, and Granzyme, and eventually kill the infected cell ⑦ Kinetics
    of SARS-CoV-2 infection and window of opportunity for rapamycin treatment Abbreviations:
    DAMPs: Damage Associated Molecular Paterns; PMNs : Polymorphonuclear Leukocytes
    ; ROS: Reactive Oxygen Species; DC : Dendritic Cell ; TLR : Toll Like Receptor
    ; ACE2 : Angiotensin Converting Enzyme 2; MAVS : Mitochondrial Anti-Viral Signaling;
    STC : Senescent T Cell; ETC: Effector T Cell; MTC: Memory T Cell; ARDS : acute
    respiratory distress syndrome.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pycard
  - mic
  - Ace2
  - Spsb3
  - Akt1
  - Nfkb1
  - Mtor
  - Qrsl1
  - Cd44
  - Th
  - Mavs
  - Stc1
  - Pdcd1
  - Wasf1
  - Pdia3
  - P4hb
  - Padi2
  - Tnfrsf9
  - Tnf
  - Cxcl10
  - Mcpt1
  - Ccl2
  - Pd
  - Cd2
  - Ccnd2
  - Mela
  - Gm42368
  - Tbce
  - Hand1
  - Nelfcd
  - Slc22a18
  - Nox3
  - Safb
  - Asprv1
  - Il1
  - Tbx21
  - H17
  - H1f7
  - STS
  - PYCARD
  - TLR1
  - TLR2
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR10
  - ACE2
  - NINL
  - PHGDH
  - AKT1
  - AKT2
  - AKT3
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - MTOR
  - QRSL1
  - GATA1
  - GATA2
  - GATA3
  - GATA4
  - GATA5
  - GATA6
  - CD44
  - TH
  - MAVS
  - STC1
  - IFNA1
  - PDCD1
  - RPL17
  - SNCA
  - SPATA2
  - RPL17-C18orf32
  - WASF1
  - P4HB
  - PADI1
  - PDIA2
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - TNFRSF9
  - TNF
  - CCL2
  - CD2
  - IH
  - ERVW-4
  - NELFCD
  - SLC22A18
  - SAFB
  - ASPRV1
  - IL1B
  - LINC00689
  - TBX21
  - H1-7
  - FOXRED1
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - ac
  - ase
  - AstC
  - anon-92Ec
  - 18w
  - tok
  - tlr-2
  - Ace
  - Nlp
  - dc
  - Akt
  - Dif
  - dl
  - Rel
  - Tor
  - GatA
  - srp
  - pnr
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - stc
  - ck
  - Hsp83
  - SCAR
  - Pdi
  - egr
  - Gs1
  - pd
  - mid
  - Ih
  - Polr2A
  - Prim1
  - PolA1
  - PolA2
  - sv
  - Prim2
  - TH1
  - JIL-1
  - Mmp1
  - CoV-2
  - SARS-CoV
  - SARS-CoV-2
---
